Boston Trust Walden’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148M Sell
580,833
-13,228
-2% -$3.08M 1.12% 12
2026
Q1
$145M Sell
594,061
-74,565
-11% -$17.4M 1.19% 10
2025
Q4
$138M Sell
668,626
-45,968
-6% -$9.09M 1.04% 12
2025
Q3
$133M Sell
714,594
-299,850
-30% -$51.4M 0.97% 16
2025
Q2
$155M Sell
1,014,444
-77,559
-7% -$11.9M 1.11% 11
2025
Q1
$181M Buy
1,092,003
+6,348
+0.6% +$993K 1.32% 6
2024
Q4
$157M Sell
1,085,655
-8,054
-0.7% -$1.25M 1.1% 10
2024
Q3
$177M Buy
1,093,709
+69,028
+7% +$11M 1.23% 10
2024
Q2
$150M Sell
1,024,681
-38,349
-4% -$5.7M 1.11% 12
2024
Q1
$168M Buy
1,063,030
+14,331
+1% +$2.28M 1.2% 11
2023
Q4
$164M Buy
1,048,699
+19,237
+2% +$2.95M 1.24% 12
2023
Q3
$160M Buy
1,029,462
+13,898
+1% +$2.29M 1.34% 10
2023
Q2
$168M Buy
1,015,564
+19,919
+2% +$3.21M 1.38% 7
2023
Q1
$154M Buy
995,645
+13,258
+1% +$2.14M 1.33% 8
2022
Q4
$174M Buy
982,387
+74,831
+8% +$12.9M 1.53% 4
2022
Q3
$148M Buy
907,556
+78,136
+9% +$13.2M 1.47% 4
2022
Q2
$147M Buy
829,420
+62,503
+8% +$11.1M 1.39% 8
2022
Q1
$136M Buy
766,917
+45,865
+6% +$7.8M 1.12% 11
2021
Q4
$123M Buy
721,052
+68,381
+10% +$11.2M 0.99% 16
2021
Q3
$105M Buy
652,671
+28,609
+5% +$4.88M 0.93% 20
2021
Q2
$103M Sell
624,062
-10,322
-2% -$1.71M 0.91% 20
2021
Q1
$104M Buy
634,384
+501
+0.1% +$81.1K 1.01% 16
2020
Q4
$99.8M Buy
633,883
+2,211
+0.4% +$326K 1.06% 13
2020
Q3
$94M Sell
631,672
-1,366
-0.2% -$202K 1.17% 10
2020
Q2
$89M Sell
633,038
-6,481
-1% -$944K 1.2% 11
2020
Q1
$83.9M Sell
639,519
-34,758
-5% -$4.93M 1.34% 10
2019
Q4
$98.4M Sell
674,277
-74,132
-10% -$10.1M 1.14% 13
2019
Q3
$96.8M Sell
748,409
-21,389
-3% -$2.82M 1.22% 13
2019
Q2
$107M Sell
769,798
-1,383
-0.2% -$191K 1.4% 11
2019
Q1
$108M Sell
771,181
-39,906
-5% -$5.35M 1.47% 10
2018
Q4
$105M Sell
811,087
-5,222
-0.6% -$728K 1.67% 6
2018
Q3
$113M Buy
816,309
+2,924
+0.4% +$389K 1.55% 9
2018
Q2
$98.7M Buy
813,385
+2,786
+0.3% +$348K 1.45% 9
2018
Q1
$104M Buy
810,599
+255
+0% +$34.5K 1.58% 7
2017
Q4
$113M Buy
810,344
+5,772
+0.7% +$804K 1.66% 5
2017
Q3
$105M Buy
804,572
+4,470
+0.6% +$593K 1.63% 5
2017
Q2
$106M Buy
800,102
+6,373
+0.8% +$813K 1.7% 4
2017
Q1
$98.9M Sell
793,729
-4,470
-0.6% -$534K 1.54% 3
2016
Q4
$92M Buy
798,199
+7,026
+0.9% +$812K 1.45% 3
2016
Q3
$93.5M Buy
791,173
+14,445
+2% +$1.75M 1.54% 3
2016
Q2
$94.2M Buy
776,728
+17,594
+2% +$2M 1.61% 1
2016
Q1
$82.1M Sell
759,134
-626
-0.1% -$64.8K 1.43% 3
2015
Q4
$78M Sell
759,760
-2,356
-0.3% -$237K 1.45% 5
2015
Q3
$71.1M Sell
762,116
-463
-0.1% -$44.8K 1.19% 7
2015
Q2
$74.3M Sell
762,579
-1,722
-0.2% -$172K 1.13% 5
2015
Q1
$76.9M Buy
764,301
+59,652
+8% +$6.07M 1.14% 5
2014
Q4
$73.7M Buy
704,649
+67,568
+11% +$7.12M 1.1% 7
2014
Q3
$67.9M Buy
637,081
+29,120
+5% +$3.02M 1.05% 8
2014
Q2
$63.6M Buy
607,961
+15,265
+3% +$1.54M 0.92% 15
2014
Q1
$58.2M Buy
592,696
+3,739
+0.6% +$347K 0.86% 27
2013
Q4
$53.9M Sell
588,957
-8,342
-1% -$769K 0.79% 35
2013
Q3
$51.8M Sell
597,299
-2,005
-0.3% -$180K 0.79% 34
2013
Q2
$51.5M Buy
+599,304
New +$50.9M 0.83% 28

Other funds holding JNJ

Boston Trust Walden's JNJ Position: Q2 2026 in Review

Boston Trust Walden reduced its Johnson & Johnson (JNJ) stake by 2.2% in Q2 2026, selling an estimated $3.08M and leaving 580,833 shares worth $148M. The position accounts for 1.12% of the portfolio, ranked #12.

Boston Trust Walden first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $181M in Q1 2025. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Boston Trust Walden held 580,833 shares of Johnson & Johnson worth $148M as of Q2 2026.
  • Boston Trust Walden sold 13,228 Johnson & Johnson shares in Q2 2026, an estimated $3.08M.
  • Johnson & Johnson made up 1.12% of Boston Trust Walden's portfolio in Q2 2026, its #12 holding.
  • Boston Trust Walden first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Boston Trust Walden's Johnson & Johnson position peaked at $181M in Q1 2025.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.